Halma buys Infinite Leap for up to $47m
Halma
2,722.00p
16:40 27/12/24
Halma said on Friday that it has bought Infinite Leap for its medical sector business, CenTrak, for up to $47m (£35m).
Electronic & Electrical Equipment
10,088.09
16:29 27/12/24
FTSE 100
8,149.78
16:54 27/12/24
FTSE 350
4,495.62
16:29 27/12/24
FTSE All-Share
4,453.14
17:05 27/12/24
CenTrak provides real-time location services for healthcare facilities. Based in North Dakota, USA, Infinite Leap is a healthcare consulting and services provider for real-time location technologies, which is also developing unique new hardware and software solutions for applications adjacent to CenTrak's core market.
The initial cash consideration is $30m (£22m). There is also an additional consideration of up to $17m (£13m) based on growth targets in each of the two financial years to 30 September 2023.
For the year to 31 March 2021, Infinite Leap's unaudited revenue was $6.8m (£5m).
Chief executive officer Andrew Williams said: "Infinite Leap is an exciting acquisition that will enhance CenTrak's capabilities as an end-to-end enterprise solutions provider for healthcare organisations.
"It will enable CenTrak to broaden its services, solutions and technologies to support the growing needs of healthcare providers, particularly larger organisations with networks of healthcare facilities, in the post-pandemic world."